Furthermore, KRT6A is recognized for its involvement in cell migration and the epithelial–mesenchymal transition (EMT) process across various cancer types, such as lung adenocarcinoma [118,119], colorectal [120], and pancreatic cancer [121]. Here, KRT6A is linked to familial pancreatic carcinoma.